📉 The Financial Deep Dive
The Numbers:
Yasho Industries Limited delivered a strong Q3 FY26 performance, with Revenue from Operations surging 35% YoY to ₹201.83 Cr, and a healthy 10% QoQ increase. EBITDA also saw a notable 21% YoY jump to ₹33.62 Cr, though it saw a marginal 1% QoQ rise. The most significant turnaround was in Profit After Tax (PAT), which swung from a loss of -₹0.82 Cr in Q3 FY25 to a profit of ₹4.496 Cr in Q3 FY26. Earnings Per Share (EPS) reflected this, moving from -₹0.68 to ₹3.73 YoY.
The Quality:
While revenue and PAT showed robust growth, EBITDA margin experienced a slight compression, falling to 16.65% in Q3 FY26 from 18.50% in Q3 FY25. This was partly attributed to the Pakhajan facility operating below optimal utilization levels. However, the overall financial health improved markedly due to a significant reduction in finance costs, which decreased YoY to ₹136.19 Cr. This, coupled with operational efficiencies and volume leverage, propelled Profit Before Tax (PBT) to ₹56.65 Cr, a substantial improvement from a loss of ₹18.70 Cr in the prior year's quarter.
For the nine months ended FY26 (9MFY26), Revenue grew 19% YoY to ₹583.76 Cr, EBITDA increased 20% YoY to ₹99.74 Cr, and PAT saw a massive jump of over 1100% YoY to ₹12.9981 Cr. The 9MFY26 EBITDA margin stood at 17.06%, slightly higher than 16.92% in 9MFY25.
The Grill:
Management commentary highlighted disciplined cost management and operational efficiencies as key drivers for EBITDA. The Pakhajan facility's underutilization poses a short-term drag on margins, but its infrastructure is geared for substantial long-term growth. The company is actively pursuing strategic expansions to leverage its capacities.
🚩 Risks & Outlook
The Pakhajan facility's current sub-optimal utilization is a factor to monitor for margin performance in the immediate term. However, its long-term potential, designed for 15-25% annual growth and projected revenue of ₹1500 Cr, is a significant tailwind.
The company is investing in future growth with two new manufacturing lines deployed at an investment of ₹25.9 Crores, expected to commence commercial production from Q1 FY27. Furthermore, a large, fully customer-funded strategic manufacturing project with an MNC, valued at an estimated ₹85-90 Crores, is slated for commercialization from Q1 FY28. These strategic moves underscore a clear focus on expanding revenue streams and market presence, supported by an expected incremental Capex to revenue ratio of 4:1.